Question: If Implant feels they really gotta keep the R&D going, then why don't they simply take out a loan from somebody for a couple of $million to pay off the interest owed to DMRJ to avoid the dilution from converts?
Answer?: They may still fear that if things go south with TSA, they will need to refinance again in March, and that DMRJ may not be willing to refinance if they see that they can convert those .08 shares, but they may not be able to get anybody else to refinance either. That puts the very future of Implant Sciences in jeapardy since DMRJ could declare a default and take over control of the company and sell it to whoever they want, including Morpho.
IOW it's simply a matter of not putting the cart before the horse in order to ensure survival.
Is that the answer? If so, are the answers given in the conf call really all that surprising?